MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Alere’s losses break the billion mark
Alere Inc. (NYSE:ALR) reported a loss of $1.04 billion, or $12.23 per diluted share, on sales of $578.8 million during the three months ended Dec. 31. That compares with a loss of $3.1 million, or 8 cents per diluted share, on sales of $546.2 million during the same period last year.
Full-year losses were $1.02 billion, or $12.33 per diluted share, on sales of $2.16 billion. That compares with profits of $33.7 million, or 13 cents per diluted share, on sales of $1.92 billion in 2009.
Read more
SonoSite profits triple
SonoSite Inc. (NSDQ:SONO) reported a profit of $5.8 million, or 41 cents per diluted share, on sales of $89.3 million during the three months ended Dec. 31, 2010. That compares with a profit of $2.2 million, or 13 cents per diluted share, on sales of $69.7 million during the same period in 2009.
Full-year profits were $10.0 million, or 66 cents per diluted share, on sales of $275.4 million. That compares with profits of $3.3 million, or 19 cents per diluted share, on sales of $227.4 million in 2009.
Read more
CryoLife profits dive despite increased sales
CryoLife Inc. (NYSE:CRY) reported profits of $2.1 million, or 8 cents per diluted share, on sales of $14.0 million during the three months ended Dec. 31, 2010. That compares with profits of $2.4 million, or 8 cents per diluted share, on sales of $13.8 million during the same period in 2009.
Full-year profits were $3.9 million, or 14 cents per diluted share, on sales of $59.7 million. That compares with profits of $8.7 million, or 24 cents per diluted share, on sales of $56.5 million in 2009.
Read more
Spectranetics peeks into the black in Q4
Spectranetics Corp. (NSDQ:SPNC) reported profits of $513,000, or 2 cents per diluted share, on sales of $29.3 million during the three months ended Dec. 31. That compares with a loss of $5.7 million, or 17 cents per diluted share, on revenue of $29.7 million during the same period last year.
Full-year losses were $13.1 million, or 39 cents per diluted share, on sales of $117.9 million. That compares with losses of $13.4 million, or 41 cents per diluted share, on sales of $114.8 million in 2009.
Read more
NxStage Medical losses ease on increased revenue
NxStage Medical Inc. (NSDQ:NXTM) reported a loss of $6.3 million, or 13 cents per diluted share, on revenue of $49.8 million during the three months ended Dec. 31. That compares with a loss of $8.7 million, or 19 cents per diluted share, on revenue of $40.5 million during the same period last year.
Full-year losses were $31.7 million, or 66 cents per diluted share, on sales of $179.2 million. That compares with losses of $43.5 million, or 93 cents per diluted share, on sales of $148.7 million in 2009.
Read more
BioClinica profits slop despite sales bump
BioClinica Inc. (NSDQ:BIOC) reported a profit of $831,000, or 6 cents per diluted share, on sales of $19.5 million during the three months ended Dec. 31. That compares with profits of $943,000, or 7 cents per diluted share, on sales of $20.2 million during the same period last year.
Full-year profits were $2.8 million, or 17 cents per diluted share, on sales of $75.2 million. That compares with profits of $3.0 million, or 21 cents per diluted share, on sales of $72.7 million in 2009.
Read more
Syneron losses worsen despite tripled revenue
Syneron Medical Ltd. (NSDQ:ELOS) recorded profits of $8.4 million, or 23 cents per diluted share, on sales of $53.5 million during the three months ended Dec. 31. That compares with a loss of $4.3 million, or 19 cents per diluted share, on sales of $46.7 million during the same period last year.
Full-year losses were $25.5 million, or 74 cents per diluted share, on sales of $189.5 million. That compares with a loss of $23.6 million, or 86 cents per diluted share, on sales of $54.7 million in 2009.
Read more
IntriCon
IntriCon Corp. (NSDQ:IIN) reported a loss of $169,000 or 3 cents per diluted share, on sales of $14.5 million during the three months ended Dec. 31. That compares with a loss of $1.6 million, or 29 cents per diluted share, on sales of $14.2 million during the same period last year.
Full-year profits were $361,000, or 7 cents per diluted share, on sales of $58.7 million. That compares with a loss of $3.9 million, or 73 cents per diluted share, on sales of $51.7 million in 2009.
Read more
Merit Medical
Merit Medical Systems Inc. (NSDQ:MMSI) reported profits of $4.2 million, or 15 cents per diluted share, on sales of $81.2 million during the three months ended Dec. 31. That compares with profits of $5.1 million, or 18 cents per diluted share, on sales of $67.5 million during the same period in 2009.
Full-year profits were $12.5 million, or 43 cents per diluted share, on sales of $296.8 million. That compares with profits of $22.5 million, or 79 cents per diluted share, on sales of $257.5 million in 2009.
Read more